checkAd

    DGAP-Adhoc  490  0 Kommentare aap Implantate AG: 51% sales increase to EUR 9.8 million in the first quarter 2012



    aap Implantate AG  / Key word(s): Development of Sales/Quarter Results

    03.04.2012 10:25

    Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
    by DGAP - a company of EquityStory AG.
    The issuer is solely responsible for the content of this announcement.




    Preliminary figures indicate that aap Implantate AG (XETRA: AAQ.DE), a
    global medical device company focused on innovative trauma products and
    biomaterials for the orthopaedic market, achieved total sales in the first
    quarter of 2012 of EUR 9.8 million, a 51% increase on the previous year´s
    figure of EUR 6.5 million. The sales growth was driven by an 18% increase
    in sales on product level to EUR 7.7 million (previous year: EUR 6.5
    million) as well as from the sales of EUR 2.1 million from the exclusive
    license agreement with a world-leading medical technology company announced
    on March 23, 2012.

    Based on the sales on product level in the first quarter 2012 and the
    Company´s goal of achieving profitable growth, the Company anticipates that
    EBITDA growth on product level in the first quarter 2012 will be stronger
    than the sales increase on product level. In addition, based on the sales
    on product level for the first quarter 2012, the management board of aap is
    reiterating its full year 2012 outlook for a 10% sales increase on product
    level.

    The Company´s Q1 2012 report is scheduled for publication on May 15, 2012.

    Contact:   
    aap Implantate AG; Marc Heydrich; Investor Relations; Lorenzweg 5; D-12099
    Berlin   Tel.:  ++49/30/750 19 - 134; Fax.: ++49/30/750 19 - 290;
    m.heydrich@aap.de

    03.04.2012 DGAP´s Distribution Services include Regulatory Announcements,
    Financial/Corporate News and Press Releases.
    Media archive at www.dgap-medientreff.de and www.dgap.de




    Language:     English
    Company:      aap Implantate AG
                  Lorenzweg 5
                  12099 Berlin
                  Germany
    Phone:        +49 (0) 30 75 01 90
    Fax:          +49 (0) 30 75 01 91 11
    E-mail:       info@aap.de
    Internet:     www.aap.de
    ISIN:         DE0005066609
    WKN:          506660
    Listed:       Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr
                  in Berlin, Düsseldorf, Hamburg, Hannover, München, Stuttgart

    End of Announcement                             DGAP News-Service







    EQS Group AG
    0 Follower
    Autor folgen

    Verfasst von EQS Group AG
    DGAP-Adhoc aap Implantate AG: 51% sales increase to EUR 9.8 million in the first quarter 2012 aap Implantate AG  / Key word(s): Development of Sales/Quarter Results03.04.2012 10:25Dissemination of an Ad hoc announcement according to § 15 WpHG, transmittedby DGAP - a company of EquityStory AG.The issuer is solely responsible for the …

    Schreibe Deinen Kommentar

    Disclaimer